Wockhardt announces successful initiation of Global Phase 3 Clinical Study of its novel antibiotic WCK 5222
WCK 5222 is a Super-drug which is entirely a new class of antibiotic known as "?-lactam ENHANCER".
WCK 5222 is a Super-drug which is entirely a new class of antibiotic known as "?-lactam ENHANCER".
Pfizer plans to submit an sBLA by the end of this year, subject to discussions with U.S. FDA
Sanofi will begin to ship their vaccines helping to ensure more people will be immunized
V116 designed to target serotypes that account for 85% of all invasive pneumococcal disease in individuals aged 65 and over in the United States as of 2019
GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones
Boehringer Ingelheim continues to innovate to enhance the customer experience and improve animal health and well-being
Nirsevimab is the first investigational immunization designed to protect all infants across the RSV season with a single dose
Novel approach driven by GN Corp Japan with potentials in neurological illnesses
Fujifilm has been at the forefront of medical imaging and healthcare informatics. It’s developing new AI platforms to address medical challenges. Chander Shekhar Sibal, Sr. Vice-President, Fujifilm India gives us an insight in an interview with Thomas C. Thottathil, Editor, indianpharmapost.com
The medical team led by Dr. Babu Ezhumalai implanted the dual-chamber leadless pacemaker through a non-surgical procedure successfully
Subscribe To Our Newsletter & Stay Updated